168 related articles for article (PubMed ID: 29483964)
1. Role of Postoperative Concurrent Chemoradiotherapy for Esophageal Carcinoma: A meta-analysis of 2165 Patients.
Kang J; Chang JY; Sun X; Men Y; Zeng H; Hui Z
J Cancer; 2018; 9(3):584-593. PubMed ID: 29483964
[No Abstract] [Full Text] [Related]
2. Addition of Induction or Consolidation Chemotherapy in Definitive Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone for Patients With Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis.
Wang J; Xiao L; Wang S; Pang Q; Wang J
Front Oncol; 2021; 11():665231. PubMed ID: 34589418
[TBL] [Abstract][Full Text] [Related]
3. High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis.
Sun X; Wang L; Wang Y; Kang J; Jiang W; Men Y; Hui Z
Front Oncol; 2020; 10():1222. PubMed ID: 32850362
[No Abstract] [Full Text] [Related]
4. Concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locally advanced cervical cancer: A systematic review and meta-analysis.
Liu H; Ma X; Sun C; Wu M; Xu Z; Zhou S; Yao N; Liu S; Qin X; Han Z
Front Oncol; 2022; 12():997030. PubMed ID: 36568251
[TBL] [Abstract][Full Text] [Related]
5. Endostar (rh-endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis.
Yuan M; Zhai Y; Men Y; Wang J; Deng L; Wang W; Bao Y; Yang X; Sun S; Ma Z; Liu Y; Wang J; Zhu H; Hui Z
Thorac Cancer; 2021 Dec; 12(23):3208-3215. PubMed ID: 34676669
[TBL] [Abstract][Full Text] [Related]
6. The impact of radiation dose on the efficacy of definitive chemoradiotherapy in patients with locally advanced esophageal carcinoma: a systematic review and meta-analysis.
Luo D; Zhong Q; Zhu X
Cancer Biol Ther; 2023 Dec; 24(1):1-10. PubMed ID: 36519807
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit of induction chemotherapy in treatment for locally advanced nasopharyngeal carcinoma--A time-to-event meta-analysis.
Song Y; Wang W; Tao G; Zhou X
Oral Oncol; 2015 Aug; 51(8):764-9. PubMed ID: 26050095
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Survival in Nonsurgical Esophageal Cancer Patients Who Received Consolidation Chemotherapy Compared With Patients Who Received Concurrent Chemoradiotherapy Alone: A Systematic Review and Meta-Analysis.
Xia X; Liu Z; Qin Q; Di X; Zhang Z; Sun X; Ge X
Front Oncol; 2020; 10():604657. PubMed ID: 33489910
[TBL] [Abstract][Full Text] [Related]
9. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiotherapy alone vs. chemoradiotherapy and hysterectomy for locally advanced cervical cancer: A systematic review and updated meta-analysis.
Lu W; Lu C; Yu Z; Gao L
Oncol Lett; 2021 Feb; 21(2):160. PubMed ID: 33552278
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiotherapy with hyperthermia versus chemoradiotherapy alone in locally advanced cervical cancer: a systematic review and meta-analysis.
Yea JW; Park JW; Oh SA; Park J
Int J Hyperthermia; 2021; 38(1):1333-1340. PubMed ID: 34477028
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of safety profile of high-dose concurrent chemoradiotherapy for patients with oesophageal squamous cell carcinoma.
Ren X; Wang L; Han C; Ren L
Radiother Oncol; 2018 Nov; 129(2):293-299. PubMed ID: 30270099
[TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis.
Zhang L; Jiang N; Shi Y; Li S; Wang P; Zhao Y
Sci Rep; 2015 Jun; 5():10798. PubMed ID: 26041604
[TBL] [Abstract][Full Text] [Related]
14. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
[No Abstract] [Full Text] [Related]
15. Comparative study of radiotherapy plus erlotinib versus chemoradiotherapy for elderly patients with esophageal cancer: a propensity score-matched analysis.
Song T; Du D; Zhang X; Fang M; Wu S
Dis Esophagus; 2017 Sep; 30(9):1-10. PubMed ID: 28859362
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients.
Chen CY; Li CC; Chien CR
World J Surg Oncol; 2018 Jul; 16(1):141. PubMed ID: 30007409
[TBL] [Abstract][Full Text] [Related]
17. [The efficacy and safety of high dose versus standard dose radiotherapy in concurrent chemoradiotherapy for patients with esophageal squamous cell carcinoma].
Ren XJ; Wang L; Han C; Liu LL
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):135-139. PubMed ID: 30862144
[No Abstract] [Full Text] [Related]
18. Paclitaxel combined with platinum (PTX) versus fluorouracil combined with cisplatin (PF) in the treatment of unresectable esophageal cancer: a systematic review and meta-analysis of the efficacy and toxicity of two different regimens.
Xu L; Chen X; Wang L; Han J; Wang Q; Liu S; Zhang X; Han C
J Gastrointest Oncol; 2023 Apr; 14(2):1037-1051. PubMed ID: 37201087
[TBL] [Abstract][Full Text] [Related]
19. Induction Chemotherapy plus Concurrent Chemoradiotherapy vs Concurrent Chemoradiotherapy in Elderly Patients with Advanced Nasopharyngeal Carcinoma.
Wang C; Tang X; Wang J; Song J; Xu Y
Otolaryngol Head Neck Surg; 2017 Aug; 157(2):233-238. PubMed ID: 28418781
[TBL] [Abstract][Full Text] [Related]
20. Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A systematic review and meta-analysis.
Tan TH; Soon YY; Cheo T; Ho F; Wong LC; Tey J; Tham IWK
Radiother Oncol; 2018 Oct; 129(1):10-17. PubMed ID: 29555182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]